Answers are grounded in this paper and cite their sources.
response and survival compared with aminoglutethimide alone (R Murray, personal communication).Further studies are required, but we doubt whether combination endocrine treatment is likely to confer appreciable advantage in this disease.
No takes yet. Share an insight, caveat, or question.
Morgan-Capner et al. (1983) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: